Ar Santé Representación Técnica y Legal ISP Chile vs bioaccess® Registration Holder

Ar Santé vs bioaccess®: what Ar Santé publishes, and when a one-country or dossier partner is enough versus the bioaccess® registration holder across Latin America.

Ar Santé shows up when manufacturers search for a Latin American registration holder or sanitary-registration partner. This article uses only what Ar Santé publishes on its own site (arsante.cl/servicios/representacion-tecnica-legal), then compares it with the multi-country subscription from bioaccess®. It is a practitioner comparison, not a teardown.

What Ar Santé publishes

Ar Santé is a Chilean regulatory firm founded by a pharmaceutical chemist. Its technical and legal representation page is aimed at foreign companies without a local structure, and at importers, distributors and establishments that need a technical role or representation before ISP or SEREMI. Ar Santé first assesses whether the operation needs representation and of what type, then defines roles, limits, signatures and responsibilities and keeps a record of changes and obligations. It says the scope of legal representation must be defined case by case and that it does not replace legal counsel.

Ar Santé vs bioaccess®

Dimension Ar Santé bioaccess®
Public product Technical / legal representation before ISP and SEREMI, scoped case by case LATAM medical device registration: registration, in-country holder, certified translations, government fees up to a stated cap, tecnovigilancia (import shipments quoted separately)
Geography Chile 19 LATAM markets
Public pricing None published Published two-part pricing: a one-time registration fee by country and class, plus an annual holder fee from year 2 (rate card)
Holder vs distributor Maps responsibilities between the company, the titular, the importer, the distributor and the technical professional; the page does not say Ar Santé holds the registration Holds through its own in-country entities, with defined transfer provisions; the registration is never leverage
Bridge from a clinical trial None published Trial-to-Market continuity: the same partner that ran your FIH study can carry registration (see market access)

Where each one fits

If Chile is the only market and you need help deciding which local representative role applies, Ar Santé publishes exactly that assessment.

The LATAM medical device registration service from bioaccess® is a different product. bioaccess® registers already FDA-cleared or CE-marked devices and holds them through its own in-country entities across 19 Latin American markets, including COFEPRIS, ANVISA, INVIMA, ANMAT, ISP and DIGEMID. Pricing is published as two parts: a one-time registration fee by country and device class, plus an annual holder fee from year 2 (see the rate card). Initial government fees and certified translations are included up to a stated cap, and the first 12 months of holder service are included (importer-of-record shipments are priced separately on the hub). For multi-country pricing, contact us or see the rate card. The registration is held for the manufacturer’s benefit, with defined transfer provisions if you ever change partners or set up your own entity.

One country and one local partner is enough? Hire the firm that publishes that job. Several LATAM labels under one holder who is not your distributor? Start at bioaccess® market access, read the LATAM importer of record guide, try the LATAM Launch Calculator, or request a registration quote.

Competitor facts from the Ar Santé public pages linked above, reviewed for bioaccess® competitive research (Aug 2026–Nov 2026). Claims are theirs. No invented clients, prices or contacts.

← Back to Blog · Contact bioaccess®